Comparison of the effect of rocuronium dosing based on corrected or lean body weight on rapid sequence induction and neuromuscular blockade duration in obese female patients

References

1. ↵
   1. World Health Organization

   (1997) Report of a WHO consultation on obesity: preventing and managing the global epidemic (World Health Organization, Geneva (CH)).
2. ↵
   1. Catenacci VA,
   2. Hill JO,
   3. Wyatt HR

   (2009) The obesity epidemic. Clin Chest Med 30:415–444.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Turkey Health Ministry

   (2014) Survey of Turkish Nutrition and Health 2010. Investigation of Nutritional Status and Habits Evaluation Results (Turkey Health Ministry, Ankara (Turkey)).
4. ↵
   1. Popescu WM,
   2. Schwartz JJ

   (2007) Perioperative considerations for the morbidly obese patient. Advances in Anesthesia 25:59–77.

   OpenUrl
5. ↵
   1. Pelosi P,
   2. Gregoretti C

   (2010) Perioperative management of obese patients. Best Pract Res Clin Anaesthesiol 24:211–225.

   OpenUrlCrossRefPubMed
6. ↵
   1. Magorian T,
   2. Flannery KB,
   3. Miller RD

   (1993) Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients. Anesthesiology 79:913–918.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Cheymol G

   (2000) Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet 39:215–231.

   OpenUrlCrossRefPubMedWeb of Science
8. 1. Adams JP,
   2. Murphy PG

   (2000) Obesity in anaesthesia and intensive care. Br J Anaesth 85:91–108.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Leykin Y,
   2. Pellis T,
   3. Lucca M,
   4. Lomangino G,
   5. Marzano B,
   6. Gullo A

   (2004) The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth Analg 99:1086–1089.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Puhringer FK,
    2. Khuenl-Brady KS,
    3. Mitterschiffthaler G

    (1995) Rocuronium bromide: time-course of action in underweight, normal weight, overweight and obese patients. Eur J Anaesthesiol 11:107–110.

    OpenUrl
11. ↵
    1. Meyhoff CS,
    2. Lund J,
    3. Jenstrup MT,
    4. Claudius C,
    5. Sorensen AM,
    6. Viby-Mogensen J,
    7. et al.

    (2009) Should dosing of rocuronium in obese patients be based on ideal or corrected body weight? Anesth Analg 109:787–792.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Ingrande J,
    2. Lemmens HJ

    (2010) Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth 105:16–23.

    OpenUrl
13. ↵
    1. Baerdemaeker LEC,
    2. Mortier EP,
    3. Struys M

    (2004) Pharmacokinetics in obese patients. Contin Educ Anaesth Crit Care Pain 4:152–155.

    OpenUrlCrossRef
14. ↵
    1. Collis T,
    2. Devereux RB,
    3. Roman MJ,
    4. de Simone G,
    5. Yeh J,
    6. Howard BV,
    7. et al.

    (2001) Relations of stroke volume and cardiac output to body composition: the strong heart study. Circulation 103:820–825.

    OpenUrlAbstract/FREE Full Text
15. ↵
    1. Salazar DE,
    2. Corcoran GB

    (1988) Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med 84:1053–1060.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    1. Friesen JH

    (2013) Lean-scaled weight: a proposed weight scalar to calculate drug doses for obese patients. Can J Anaesth 60:214–215.

    OpenUrlCrossRef
17. ↵
    1. Ingrande J,
    2. Brodsky JB,
    3. Lemmens HJ

    (2011) Lean body weight scalar for the anesthetic induction of propofol in morbidly obese subjects. Anesth Analg 113:57–62.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    1. Fuchs-Buder T,
    2. Claudius C,
    3. Skovgaard LT,
    4. Eriksson LI,
    5. Mirakhur RK,
    6. Viby-Mogensen J

    (2007) Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 51:789–808.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    1. Adamus M,
    2. Gabrhelik T,
    3. Marek O

    (2008) Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium. Eur J Anaesthesiol 25:589–595.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    1. Curley GF

    (2011) Rapid sequence induction with rocuronium - a challenge to the gold standard. Critical Care 15:190.

    OpenUrlPubMed
21. ↵
    1. Gaszynski TM,
    2. Szewczyk T

    (2011) Rocuronium for rapid sequence induction in morbidly obese patients: a prospective study for evaluation of intubation conditions after administration 1.2 mg kg-¹ideal body weight of rocuronium. Eur J Anaesthesiol 28:609–610.

    OpenUrlCrossRefPubMed
22. ↵
    1. Schultz P,
    2. Ibsen M,
    3. Østergaard D,
    4. Skovgaard LT

    (2001) Onset and duration of action of rocuronium--from tracheal intubation, through intense block to complete recovery. Acta Anaesthesiol Scand 45:612–617.

    OpenUrlCrossRefPubMedWeb of Science
23. ↵
    1. Aytac I,
    2. Postacı A,
    3. Aytac B,
    4. Sacan O,
    5. Alay GH,
    6. Celik B,
    7. et al.

    (2014) Survey of postoperative residual curarization, acute respiratory events and approach of anesthesiologists. Rev Bras Anestesiol.
24. ↵
    1. Bevan DR,
    2. Smith CE,
    3. Donati F

    (1988) Postoperative neuromuscular blockage: a comparison between atracurium, vercuronium and pancuronium. Anesthesiology 69:272–276.

    OpenUrlCrossRefPubMedWeb of Science